Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CSGP vs MOVE vs Z vs MNMD

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CSGP
CoStar Group, Inc.

Real Estate - Services

Real EstateNASDAQ • US
Market Cap$14.79B
5Y Perf.-57.5%
MOVE
Movano Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$816M
5Y Perf.-98.4%
Z
Zillow Group, Inc. Class C

Internet Content & Information

Communication ServicesNASDAQ • US
Market Cap$10.47B
5Y Perf.-66.4%
MNMD
Mind Medicine (MindMed) Inc.

Biotechnology

HealthcareNASDAQ • CA
Market Cap$2.04B
5Y Perf.-54.8%

CSGP vs MOVE vs Z vs MNMD — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CSGP logoCSGP
MOVE logoMOVE
Z logoZ
MNMD logoMNMD
IndustryReal Estate - ServicesMedical - DevicesInternet Content & InformationBiotechnology
Market Cap$14.79B$816M$10.47B$2.04B
Revenue (TTM)$3.41B$500K$2.48B$0.00
Net Income (TTM)$25M$-17M$-32M$-184M
Gross Margin77.4%-270.2%74.9%
Operating Margin-0.8%-31.6%-3.7%
Forward P/E25.8x19.7x
Total Debt$1.14B$186K$93M$0.00
Cash & Equiv.$1.73B$8M$768M$258M

CSGP vs MOVE vs Z vs MNMDLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CSGP
MOVE
Z
MNMD
StockMar 21May 26Return
CoStar Group, Inc. (CSGP)10042.5-57.5%
Movano Inc. (MOVE)1001.6-98.4%
Zillow Group, Inc. … (Z)10033.6-66.4%
Mind Medicine (Mind… (MNMD)10045.2-54.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: CSGP vs MOVE vs Z vs MNMD

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CSGP leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Zillow Group, Inc. Class C is the stronger pick specifically for valuation and capital efficiency. MNMD also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
CSGP
CoStar Group, Inc.
The Real Estate Income Play

CSGP carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.80
  • Rev growth 18.7%, EPS growth -95.1%, 3Y rev CAGR 14.2%
  • 18.7% FFO/revenue growth vs MNMD's -64.9%
  • 0.7% margin vs MOVE's -34.1%
Best for: income & stability and growth exposure
MOVE
Movano Inc.
The Secondary Option

MOVE lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
Z
Zillow Group, Inc. Class C
The Defensive Pick

Z is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.

  • Lower volatility, beta 1.32, Low D/E 1.9%, current ratio 3.13x
  • Beta 1.32, current ratio 3.13x
  • Better valuation composite
Best for: sleep-well-at-night and defensive
MNMD
Mind Medicine (MindMed) Inc.
The Long-Run Compounder

MNMD is the clearest fit if your priority is long-term compounding.

  • 5.1% 10Y total return vs CSGP's 80.5%
  • +215.9% vs CSGP's -54.7%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCSGP logoCSGP18.7% FFO/revenue growth vs MNMD's -64.9%
ValueZ logoZBetter valuation composite
Quality / MarginsCSGP logoCSGP0.7% margin vs MOVE's -34.1%
Stability / SafetyCSGP logoCSGPBeta 0.80 vs MOVE's 1.98
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)MNMD logoMNMD+215.9% vs CSGP's -54.7%
Efficiency (ROA)CSGP logoCSGP0.2% ROA vs MOVE's -306.8%

CSGP vs MOVE vs Z vs MNMD — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CSGPCoStar Group, Inc.
FY 2024
CoStar Suite
61.1%$1.0B
LoopNet
16.9%$282M
Information services
8.1%$136M
Online Marketplaces
7.8%$130M
Residential
6.0%$101M
MOVEMovano Inc.

Segment breakdown not available.

ZZillow Group, Inc. Class C
FY 2025
Sales Revenue
44.9%$1.9B
Residential Revenue
40.2%$1.7B
Rental Revenue
14.9%$630M
MNMDMind Medicine (MindMed) Inc.

Segment breakdown not available.

CSGP vs MOVE vs Z vs MNMD — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLZLAGGINGMOVE

Income & Cash Flow (Last 12 Months)

CSGP leads this category, winning 3 of 6 comparable metrics.

CSGP and MNMD operate at a comparable scale, with $3.4B and $0 in trailing revenue. CSGP is the more profitable business, keeping 0.7% of every revenue dollar as net income compared to MOVE's -34.1%. On growth, MOVE holds the edge at +60.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCSGP logoCSGPCoStar Group, Inc.MOVE logoMOVEMovano Inc.Z logoZZillow Group, Inc…MNMD logoMNMDMind Medicine (Mi…
RevenueTrailing 12 months$3.4B$500,000$2.5B$0
EBITDAEarnings before interest/tax$278M-$16M$187M-$156M
Net IncomeAfter-tax profit$25M-$17M-$32M-$184M
Free Cash FlowCash after capex$241M-$14M$264M-$161M
Gross MarginGross profit ÷ Revenue+77.4%-2.7%+74.9%
Operating MarginEBIT ÷ Revenue-0.8%-31.6%-3.7%
Net MarginNet income ÷ Revenue+0.7%-34.1%-1.3%
FCF MarginFCF ÷ Revenue+7.1%-27.1%+10.6%
Rev. Growth (YoY)Latest quarter vs prior year+22.5%+60.0%+16.4%
EPS Growth (YoY)Latest quarter vs prior year+127.7%+53.0%+145.3%-22.0%
CSGP leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Z leads this category, winning 3 of 5 comparable metrics.

At 483.8x trailing earnings, Z trades at a 77% valuation discount to CSGP's 2102.4x P/E.

MetricCSGP logoCSGPCoStar Group, Inc.MOVE logoMOVEMovano Inc.Z logoZZillow Group, Inc…MNMD logoMNMDMind Medicine (Mi…
Market CapShares × price$14.8B$816M$10.5B$2.0B
Enterprise ValueMkt cap + debt − cash$14.2B$808M$9.8B$1.8B
Trailing P/EPrice ÷ TTM EPS2102.41x-34.72x483.78x-10.04x
Forward P/EPrice ÷ next-FY EPS est.25.78x19.65x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple83.54x
Price / SalesMarket cap ÷ Revenue4.56x805.09x4.05x
Price / BookPrice ÷ Book value/share1.76x110.89x2.27x5.56x
Price / FCFMarket cap ÷ FCF360.77x44.55x
Z leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

Z leads this category, winning 5 of 9 comparable metrics.

CSGP delivers a 0.3% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-4 for MOVE. Z carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to CSGP's 0.14x. On the Piotroski fundamental quality scale (0–9), Z scores 7/9 vs MNMD's 3/9, reflecting strong financial health.

MetricCSGP logoCSGPCoStar Group, Inc.MOVE logoMOVEMovano Inc.Z logoZZillow Group, Inc…MNMD logoMNMDMind Medicine (Mi…
ROE (TTM)Return on equity+0.3%-4.4%-0.6%-55.3%
ROA (TTM)Return on assets+0.2%-3.1%-0.6%-41.8%
ROICReturn on invested capital-0.9%-0.6%-3.9%
ROCEReturn on capital employed-0.8%-4.3%-0.7%-52.2%
Piotroski ScoreFundamental quality 0–95673
Debt / EquityFinancial leverage0.14x0.03x0.02x
Net DebtTotal debt minus cash-$589M-$8M-$675M-$258M
Cash & Equiv.Liquid assets$1.7B$8M$768M$258M
Total DebtShort + long-term debt$1.1B$186,000$93M$0
Interest CoverageEBIT ÷ Interest expense1.58x-10.38x-0.38x-14.63x
Z leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MNMD leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CSGP five years ago would be worth $4,185 today (with dividends reinvested), compared to $168 for MOVE. Over the past 12 months, MNMD leads with a +215.9% total return vs CSGP's -54.7%. The 3-year compound annual growth rate (CAGR) favors MNMD at 82.4% vs MOVE's -56.4% — a key indicator of consistent wealth creation.

MetricCSGP logoCSGPCoStar Group, Inc.MOVE logoMOVEMovano Inc.Z logoZZillow Group, Inc…MNMD logoMNMDMind Medicine (Mi…
YTD ReturnYear-to-date-46.9%+54.2%-34.0%+51.7%
1-Year ReturnPast 12 months-54.7%+52.1%-36.1%+215.9%
3-Year ReturnCumulative with dividends-53.2%-91.7%-10.6%+506.7%
5-Year ReturnCumulative with dividends-58.2%-98.3%-61.7%-58.8%
10-Year ReturnCumulative with dividends+80.5%-98.6%+62.9%+512.1%
CAGR (3Y)Annualised 3-year return-22.4%-56.4%-3.7%+82.4%
MNMD leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CSGP and MNMD each lead in 1 of 2 comparable metrics.

CSGP is the less volatile stock with a 0.80 beta — it tends to amplify market swings less than MOVE's 1.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MNMD currently trades 98.1% from its 52-week high vs CSGP's 35.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCSGP logoCSGPCoStar Group, Inc.MOVE logoMOVEMovano Inc.Z logoZZillow Group, Inc…MNMD logoMNMDMind Medicine (Mi…
Beta (5Y)Sensitivity to S&P 5000.80x1.98x1.32x1.68x
52-Week HighHighest price in past year$97.43$34.87$93.88$21.09
52-Week LowLowest price in past year$33.31$4.67$39.05$6.03
% of 52W HighCurrent price vs 52-week peak+35.8%+38.8%+46.4%+98.1%
RSI (14)Momentum oscillator 0–10034.642.649.064.9
Avg Volume (50D)Average daily shares traded6.0M70K3.6M803K
Evenly matched — CSGP and MNMD each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: CSGP as "Buy", MOVE as "Buy", Z as "Hold", MNMD as "Buy". Consensus price targets imply 83.7% upside for Z (target: $80) vs -3.3% for MNMD (target: $20).

MetricCSGP logoCSGPCoStar Group, Inc.MOVE logoMOVEMovano Inc.Z logoZZillow Group, Inc…MNMD logoMNMDMind Medicine (Mi…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuy
Price TargetConsensus 12-month target$61.91$80.00$20.00
# AnalystsCovering analysts254461
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+3.9%0.0%+6.4%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

Z leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). CSGP leads in 1 (Income & Cash Flow). 1 tied.

Best OverallZillow Group, Inc. Class C (Z)Leads 2 of 6 categories
Loading custom metrics...

CSGP vs MOVE vs Z vs MNMD: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CSGP or MOVE or Z or MNMD a better buy right now?

For growth investors, CoStar Group, Inc.

(CSGP) is the stronger pick with 18. 7% revenue growth year-over-year, versus 15. 5% for Zillow Group, Inc. Class C (Z). Zillow Group, Inc. Class C (Z) offers the better valuation at 483. 8x trailing P/E (19. 7x forward), making it the more compelling value choice. Analysts rate CoStar Group, Inc. (CSGP) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CSGP or MOVE or Z or MNMD?

On trailing P/E, Zillow Group, Inc.

Class C (Z) is the cheapest at 483. 8x versus CoStar Group, Inc. at 2102. 4x. On forward P/E, Zillow Group, Inc. Class C is actually cheaper at 19. 7x.

03

Which is the better long-term investment — CSGP or MOVE or Z or MNMD?

Over the past 5 years, CoStar Group, Inc.

(CSGP) delivered a total return of -58. 2%, compared to -98. 3% for Movano Inc. (MOVE). Over 10 years, the gap is even starker: MNMD returned +512. 1% versus MOVE's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CSGP or MOVE or Z or MNMD?

By beta (market sensitivity over 5 years), CoStar Group, Inc.

(CSGP) is the lower-risk stock at 0. 80β versus Movano Inc. 's 1. 98β — meaning MOVE is approximately 148% more volatile than CSGP relative to the S&P 500. On balance sheet safety, Zillow Group, Inc. Class C (Z) carries a lower debt/equity ratio of 2% versus 14% for CoStar Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CSGP or MOVE or Z or MNMD?

By revenue growth (latest reported year), CoStar Group, Inc.

(CSGP) is pulling ahead at 18. 7% versus 15. 5% for Zillow Group, Inc. Class C (Z). On earnings-per-share growth, the picture is similar: Zillow Group, Inc. Class C grew EPS 118. 8% year-over-year, compared to -1273. 3% for Mind Medicine (MindMed) Inc.. Over a 3-year CAGR, CSGP leads at 14. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CSGP or MOVE or Z or MNMD?

Zillow Group, Inc.

Class C (Z) is the more profitable company, earning 0. 9% net margin versus -23. 4% for Movano Inc. — meaning it keeps 0. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MNMD leads at 0. 0% versus -23. 9% for MOVE. At the gross margin level — before operating expenses — CSGP leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CSGP or MOVE or Z or MNMD more undervalued right now?

On forward earnings alone, Zillow Group, Inc.

Class C (Z) trades at 19. 7x forward P/E versus 25. 8x for CoStar Group, Inc. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for Z: 83. 7% to $80. 00.

08

Which pays a better dividend — CSGP or MOVE or Z or MNMD?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is CSGP or MOVE or Z or MNMD better for a retirement portfolio?

For long-horizon retirement investors, CoStar Group, Inc.

(CSGP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 80)). Movano Inc. (MOVE) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CSGP: +80. 5%, MOVE: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CSGP and MOVE and Z and MNMD?

These companies operate in different sectors (CSGP (Real Estate) and MOVE (Healthcare) and Z (Communication Services) and MNMD (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CSGP is a mid-cap high-growth stock; MOVE is a small-cap quality compounder stock; Z is a mid-cap high-growth stock; MNMD is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CSGP

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Gross Margin > 46%
Run This Screen
Stocks Like

MOVE

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 30%
Run This Screen
Stocks Like

Z

High-Growth Disruptor

  • Sector: Communication Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Gross Margin > 44%
Run This Screen
Stocks Like

MNMD

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CSGP and MOVE and Z and MNMD on the metrics below

Revenue Growth>
%
(CSGP: 22.5% · MOVE: 60.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.